 Regional chemotherapy colorectal liver metastases phase II evaluation hepatic arterial colorectal liver metastases results systemic chemotherapy patients liver metastases colorectal cancer dismal Regional chemotherapy method delivery cytotoxic drugs systemic toxicity use vasoactive agents arterial blood flow towards biodegradable microspheres tumour blood flow methods tumour exposure drug present patients intrahepatic arterial chemotherapy colorectal liver metastases treatment angiotensin II albumin microspheres weekly bolus intervening weeks Toxicity minimal Responses patients half deaths liver metastases quarter patients non-cancer-related causes Survival treated group historical controls results regimen activity patients colorectal liver metastases